Bayesian Capital Management’s Imperva, Inc. IMPV Stock Holding History

Bayesian Capital Management’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-9,027	Closed	-$391K	–	823
2018 Q1	$391K	Buy	+9,027	New	+$405K	0.1%	329
2017 Q3	–	Sell	-4,915	Closed	-$235K	–	715
2017 Q2	$235K	Sell	4,915 -4,800	-49%	-$224K	0.09%	347
2017 Q1	$399K	Sell	9,715 -2,000	-17%	-$83.5K	0.19%	205
2016 Q4	$450K	Buy	+11,715	New	+$476K	0.11%	329
2016 Q1	–	Sell	-3,406	Closed	-$216K	–	476
2015 Q4	$216K	Buy	+3,406	New	+$232K	0.31%	159

Other funds holding IMPV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Bayesian Capital Management's IMPV Position: Q2 2018 in Review

Bayesian Capital Management sold out of Imperva, Inc. (IMPV) in Q2 2018, closing a stake of 9,027 shares — an estimated $391K sold.

Bayesian Capital Management first reported a position in IMPV in Q4 2015 and held it in 5 quarters. The position peaked at $450K in Q4 2016. 188 funds tracked by Wall St. Rank hold IMPV as of Q2 2018.

Bayesian Capital Management reported no remaining Imperva, Inc. position as of Q2 2018 after selling out during the quarter.
Bayesian Capital Management sold 9,027 Imperva, Inc. shares in Q2 2018, an estimated $391K.
Bayesian Capital Management first reported a position in Imperva, Inc. in Q4 2015 and held it in 5 quarters.
Bayesian Capital Management's Imperva, Inc. position peaked at $450K in Q4 2016.
188 funds tracked by Wall St. Rank held Imperva, Inc. as of Q2 2018.

Based on Bayesian Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.